Anesthesia or sedation for gastroenterologic endoscopies

Current Opinion in Anaesthesiology

Volumn 22, Issue 4, 2009, Pages 524-531

  Luginbühl, Martin ^a   Vuilleumier, Pascal ^a   Schumacher, Peter ^a   Stüber, Frank ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Closed loop controlled administration; Endoscopy; Fospropofol; Gastroenterology; Propofol; Sedation

Indexed keywords

ALKALINE PHOSPHATASE; FENTANYL; FORMALDEHYDE; FOSPROPOFOL; MIDAZOLAM; OPIATE; PETHIDINE; PROPOFOL; VANADATE SODIUM;

ADD ON THERAPY; ANESTHESIA; ANESTHESIST; CLINICAL PROTOCOL; COLONOSCOPY; COMPUTER AIDED DESIGN; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INFUSION; DRUG OVERDOSE; DRUG SAFETY; DRUG TOLERANCE; ENDOSCOPIC ECHOGRAPHY; FATTY ACID DESATURATION; FOOD AND DRUG ADMINISTRATION; GASTROENTEROLOGY; GASTROINTESTINAL ENDOSCOPY; HUMAN; HYPERTENSION; HYPNOSIS; HYPOVENTILATION; INFUSION PUMP; LOADING DRUG DOSE; OXYGEN THERAPY; PARESTHESIA; PATIENT CONTROLLED ANALGESIA; PATIENT SATISFACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRURITUS; RESPIRATION DEPRESSION; REVIEW; RISK REDUCTION; SEDATION; SIMULATION; SINGLE DRUG DOSE; TACHYCARDIA;

ANESTHESIA; CONSCIOUS SEDATION; ENDOSCOPY, GASTROINTESTINAL; HUMANS; PROPOFOL; RESPIRATION;

EID: 68949122582     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e32832dbb7c     Document Type: Review

References (47)

1. Keren D, RainisT, Goldstein O, etal. Significant colonic neoplasia prevalence and ASGE recommendations: is it time for a change? J Clin Gastroenterol 2008; 42:886-891.
2. Radaelli F, Meucci G, Sgroi G, et al. Technical performance of colonoscopy: the key role of sedation/analgesia and other quality indicators. Am J Gastroenterol 2008; 103:1122-1130.
3. McQuaid KR, Laine L. A systematic review and meta-analysis of randomized, controlled trials of moderate sedation for routine endoscopic procedures. Gastrointest Endosc 2008; 67:910-923.
4. Rex DK, Deenadayalu V, Eid E. Gastroenterologist-directed propofol: an update. Gastrointest Endosc Clin N Am 2008; 18:71 7-725.
5. Singh H, Poluha W, Cheung M, et al. Propofol for sedation during colonoscopy. Cochrane Database Syst Rev 2008:CD006268.
6. Trummel J. Sedation for gastrointestinal endoscopy: the changing landscape. Curr Opin Anaesthesiol 2007; 20:359-364.
7. Aisenberg J, Brill JV, Ladabaum U, et al. Sedation for gastrointestinal endoscopy: new practices, new economics. Am J Gastroenterol 2005; 100:996-1000.
8. Vargo JJ. See one, do one, teach one. Gastrointest Endosc 2008; 67:419-421.
9. Rex DK, Heuss LT, Walker JA, et al. Trained registered nurses/endoscopy teams can administer propofol safely for endoscopy. Gastroenterology 2005; 129:1384-1391.
10. Vargo JJ. Big NAPS, little NAPS, mixed NAPS, computerized NAPS: what is your flavor of propofol? Gastrointest Endosc 2007; 66:457-459.
11. Heuss LT, Peter S. Propofol use by gastroenterologists: the European experience. Gastrointest Endosc Clin N Am 2008; 18:727-738.
12. Kulling D, Orlandi M, Inauen W. Propofol sedation during endoscopic procedures: how much staff and monitoring are necessary? Gastrointest Endosc 2007; 66:443-449.
13. Heuss LT, Schnieper P, Pflimlin E, et al. Nurse-administered sedation with propofol under observation of the endoscopist: a prospective observation study with more than 5000 patients. Gastroint Endosc 2003; 57:AB105.
14. Heuss LT, Schnieper P, Drewe J, et al. Risk stratification and safe administration of propofol by registered nurses supervised by the gastroenterologist: a prospective observational study of more than 2000 cases. Gastrointest Endosc 2003; 57:664-671.
15. Heuss LT, Drewe J, Schnieper P, et al. Patient-controlled versus nurse-administered sedation with propofol during colonoscopy. A prospective randomized trial. Am J Gastroenterol 2004; 99:511-518.
16. Fu ES, Downs JB, Schweiger JW, et al. Supplemental oxygen impairs detection of hypoventilation by pulse oximetry. Chest 2004; 126:1552-1558.
17. Heuss LT, Schnieper P, Drewe J, et al. Safety of propofol for conscious sedation during endoscopic procedures in high-risk patients: a prospective, controlled study. Am J Gastroenterol 2003; 98:1751-1757.
18. Fatima H, DeWitt J, LeBlanc J, etal. Nurse-administered propofol sedation for upper endoscopic ultrasonography. Am J Gastroenterol 2008; 103:1649-1656.
19. Cohen LB, Delegge MH, Aisenberg J, et al. AGA Institute review of endoscopic sedation. Gastroenterology 2007; 133:675-701.
20. Lichtenstein DR, Jagannath S, Baron TH, etal. Sedation and anesthesia in GI endoscopy. Gastrointest Endosc 2008; 68:815-826.
21. Riphaus A, Wehrmann T, Weber B, et al. S3-guidelines: sedation in gastro-intestinal endoscopy. Z Gastroenterol 2008; 46:1298-1330.
22. Vargo JJ, Ahmad AS, Aslanian HR, et al. Training in patient monitoring and sedation and analgesia. Gastrointest Endosc 2007; 66:7-10.
23. Practice guidelines for sedation and analgesia by nonanesthesiologists. Anesthesiology 2002; 96:1004-1017.
24. Gibiansky E, Struys MM, Gibiansky L, et al. AQUAVAN injection, a water-soluble prodrug of propofol, as a bolus injection: a phase I dose-escalation comparison with DIPRIVAN (part 1): pharmacokinetics. Anesthesiology 2005; 103:718-729.
25. Struys MM, De ST, Depoorter B, et al. Comparison of plasma compartment versus two methods for effect compartment: controlled target-controlled infusion for propofol. Anesthesiology 2000; 92:399-406.
26. Struys MM, Vanluchene AL, Gibiansky E, et al. AQUAVAN injection, a water-soluble prodrug of propofol, as a bolus injection: a phase I dose-escalation comparison with DIPRIVAN (part 2): pharmacodynamics and safety. Anesthesiology 2005; 103:730-743.
27. Levitzky BE, Vargo JJ. Fospropofol disodium injection for the sedation of patients undergoing colonoscopy. Ther Clin Risk Manag 2008; 4:733-738.
28. Silvestri GA, Vincent BD, Wahidi MM, et al. A phase 3, randomized, double-blind study to assess the efficacy and safety of fospropofol disodium injection for moderate sedation in patients undergoing flexible bronchoscopy. Chest 2009; 135:41-47.
29. Cohen LB. Clinical trial: a dose-response study of fospropofol disodium for moderate sedation during colonoscopy. Aliment Pharmacol Ther 2008; 27:597-608.
30. Shah A, Mistry B, Gibiansky E, Gibiansky L Fospropofol assay issues and impact on pharmacokinetic and pharmacodynamic evaluation. Anesthesiology 2008; 109:937.
31. Thompson CA. Fospropofol approved for monitored anesthesia care. Am J Health Syst Pharm 2009; 66:206.
32. Eisenach JC, Shafer SL, Pollard BJ. Fospropofol assay issues and impact on pharmacokinetic and pharmacodynamic evaluation. Anesthesiology 2008; 109:937.
33. Bhananker SM, Posner KL, Cheney FW, et al. Injury and liability associated with monitored anesthesia care: a closed claims analysis. Anesthesiology 2006; 104:228-234.
34. Gepts E, Camu F, Cockshott ID, et al. Disposition of propofol administered as constant rate intravenous infusions in humans. Anesth Analg 1987; 66: 1256-1263.
35. Marsh B, White M, Morton N, etal. Pharmacokinetic model driven infusion of propofol in children. Br JAnaesth 1991; 67:41-48.
36. Schnider TW, Minto CF, Gambus PL, et al. The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 1998; 88:1170-1182.
37. Schnider TW, Minto CF, Shafer SL, et al. The influence of age on propofol pharmacodynamics. Anesthesiology 1999; 90:1502-1516.
38. Barakat AR, Sutcliffe N, Schwab M. Effect site concentration during propofol TCI sedation: a comparison of sedation score with two pharmacokinetic models. Anaesthesia 2007; 62:661-666.
39. Billard V, Gambus PL, Chamoun N, et al. A comparison of spectral edge, delta power, and bispectral index as EEG measures of alfentanil, propofol, and midazolam drug effect. Clin Pharmacol Ther 1997; 61: 45-58.
40. Bouillon T, Bruhn J, Radu-Radulescu L, et al. Mixed-effects modeling of the intrinsic ventilatory depressant potency of propofol in the nonsteady state. Anesthesiology 2004; 100:240-250.
41. Schumacher PM, Caruso A, Hartwich V, et al. Dynamic properties of a new transcutaneous CO2 sensor: fast enough for early detection of apnea? Proceedings of the ASA Annual Meeting, Anesthesiology 105: p. A477; Chicago, Illinois, USA; 2006.
42. Caruso AL, Bouillon TW, Schumacher PM, et al. Drug-induced respiratory depression: an integrated model of drug effects on the hypercapnic and hypoxic drive. Conf Proc IEEE Eng Med Biol Soc 2007; 2007:4259-4263.
43. Hickle RS. Apparatus and method for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures. US Patent Application 2001; 2002001 7296.
44. Pambianco DJ. Future directions in endoscopic sedation. Gastrointest En-dosc Clin N Am 2008; 18:789-799.
45. Pambianco DJ, Pruit RE, Hardie R, et al. Propofol versus standard-of-care sedation for colonoscopy and esophagogastroduodenoscopy: a 1000-sub-ject randomized, controlled, multicenter, pivotal trial [abstract]. Gastroenter-ology 2008; 135:294.
46. Caruso ALG, Bouillon TW, Schumacher PM, et al. Control of drug administration during monitored anesthesia care. IEEE Trans Automation Sci Eng 2009; 6:256-264.
47. Bouillon TW, Bruhn J, Radulescu L, et al. Pharmacodynamic interaction between propofol and remifentanil regarding hypnosis, tolerance of laryngo-scopy, bispectral index, and electroencephalographic approximate entropy. Anesthesiology 2004; 100:1353-1372.